Spain

Back to map

Showing 1-9 of 9 grants

Title Institution Researcher Program Duration Total Award Amount
Pioneering Immunotherapy: Fast-Tracking PS-Liposome Treatment for Type 1 Diabetes – Final Steps of the non-regulatory Package for a Breakthrough Therapy AHEAD THERAPEUTICS S.L Bruna Barneda Zahonero Cures 15-January-2026 to 14-January-2028 $361,900.13
Antigen-specific pMHCII nanoparticle immunoregulation to enable immunosuppression-free human SC-islet replacement in T1D Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Pere Santamaria Cures 01-October-2026 to 30-September-2029 $900,000.00
Transcriptional and epigenetic regulation of an anti-diabetogenic immunoregulatory cell pathway (PI: Pere Santamaria) Fundación la Caixa Mònica Zamora Villafaina Cures 31-December-2025 to 30-December-2028 $288,310.00
Targeting microexons and neural-related splicing programs to enhance in vitro beta cell maturation (PI: Manuel Irimia) Fundación la Caixa Mònica Zamora Villafaina Cures 01-December-2025 to 30-November-2028 $576,532.00
Telomere Dynamics and Cellular Senescence in Type 1 Diabetes Exploring Biomarkers and the Impact of LRH-1/NR5A2 Activation Fundacion Publica Andaluza Progreso y Salud (Cabimer) Benoit Gauthier Cures 01-September-2025 to 31-August-2027 $599,959.50
LRH-1/NR5A2-mediated immune coupled islet remodelling: A wound healing disease modifying therapeutic approach for type 1 diabetes mellitus Fundacion Publica Andaluza Progreso y Salud (Cabimer) Benoit Gauthier Cures 01-February-2023 to 31-July-2026 $744,939.00
Proof-of-concept of a sensor for the continuous monitoring of insulin fibrillation in an insulin pump (QUALinS) Universitat Politècnica de València Jorge Bondia Improving Lives 01-April-2026 to 31-March-2027 $199,333.56
Fully-automated insulin delivery system Adaptable to the use of adjunctIve THerapies in T1D (FAITH-T1D) Universitat Politècnica de València Jorge Bondia Improving Lives 01-May-2026 to 30-April-2028 $727,636.07
Examining the role of self-metabolites as autoantigens in Type 1 Diabetes (Self-MAIT1D) University of Santiago de Compostela Iria Gomez-Tourino Cures 01-March-2023 to 29-February-2028 $996,586.00